LCIG in treatment of non‐motor symptoms in advanced Parkinson’s disease: Review of literature

BACKGROUND: For managing nonmotor symptoms (NMS) in advanced Parkinson's disease (PD), levodopa–carbidopa intestinal gel (LCIG) infusion is of interest as it shows lesser plasma fluctuations of both drugs as compared to oral levodopa–carbidopa (LC). OBJECTIVES: To highlight LCIG effect in NMS a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamel, Walaa A., Al‐Hashel, Jasem Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507541/
https://www.ncbi.nlm.nih.gov/pubmed/32677345
http://dx.doi.org/10.1002/brb3.1757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507541/
https://www.ncbi.nlm.nih.gov/pubmed/32677345
http://dx.doi.org/10.1002/brb3.1757

Ejemplares similares